Nina Chandra

About Nina Chandra

As a strategic and results-driven Clinical Operations leader, I bring over 14 years of experience delivering complex, global clinical trials across cardiology, ophthalmology, and rare diseases. I specialize in leading large-scale programs from study start-up through database lock, consistently driving execution that balances speed, quality, and patient safety within highly regulated environments. I am known for translating clinical strategy into operational excellence—optimizing trial design, accelerating site activation and enrollment, and implementing risk-based methodologies that improve performance and reduce delays. Through a data-driven and forward-thinking approach, I have successfully enhanced trial efficiency, strengthened compliance, and delivered strong financial outcomes across global portfolios. My leadership style is grounded in collaboration, accountability, and people development. I have built and mentored high-performing, cross-functional teams, fostering a culture of ownership, continuous improvement, and partnership across Clinical, Regulatory, Data Management, and Biostatistics. I am passionate about creating environments where teams thrive and deliver their best work. Throughout my career, I have consistently been recognized for driving impact, solving complex challenges, and elevating team performance. Select Achievements: Reduced trial delays by 40% across a multi-site global study by implementing streamlined processes and enhancing cross-functional communication. Improved data quality by decreasing discrepancies by 30% through development of a robust, risk-based monitoring strategy. Delivered ~$2M in cost savings through strategic budget negotiation while maintaining study quality and timelines. Increased patient retention by 25% by leading initiatives focused on patient engagement and site support.

Experience

1. Principal Clinical Trial Manager Associate Director Clinical Operations (Global)

   Syneos Health

   Jun 2024 — Present

   Provide strategic and operational leadership across global clinical programs, overseeing site management, clinical monitoring, and centralized monitoring throughout the full study lifecycle to ensure delivery aligned with quality standards, patient safety, and global regulatory requirements.• Lead and operationalize enterprise risk management strategies, including Risk-Based Monitoring (RBM), RACT, and Clinical Monitoring Plans (CMP), proactively identifying and mitigating study- and portfolio-level risks.• Drive study-level strategy by influencing protocol design, feasibility, and budget planning to optimize timelines, enrollment, and overall program execution.• Leverage advanced analytics, CTMS, and operational dashboards to monitor performance, generate actionable insights, and drive continuous improvement across studies.• Act as a senior escalation point for complex site and investigator challenges, building strong partnerships to resolve issues, maintain engagement, and protect study integrity.• Provide leadership and oversight of CRA and centralized monitoring teams, including resource planning, talent development, and performance management to ensure consistent global execution.• Partner cross-functionally with Clinical Development, Regulatory, Data Management, and Biostatistics to align on strategy, accelerate site activation and enrollment, and ensure timely database lock and study delivery.• Champion inspection readiness and quality excellence, leading audit and regulatory inspection preparedness efforts and ensuring successful outcomes through strong governance and compliance frameworks.

Education

• Meredith College

  B.A, Biological Sciences

  2005 — 2010

Skills

• Adjudication
• Ich-Gcp
• Pharmaceutical Industry
• Sop
• Fda
• Data Analysis
• Safety Management Systems
• Corporate Communications
• Microsoft Office
• Adobe Acrobat
• Gcp
• Data Management
• Edc
• Cardiology
• CRO
• Science
• Clinical Research
• Gel Electrophoresis
• Clinical Monitoring
• Management
• Pcr
• Tmf
• Pharmaceuticals
• Budget Monitoring
• Outlook
• Clinical Trials
• Diabetes